BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
HIV infection
,
Intestine
,
Autoimmunity
,
Aspirin
,
rs7903146
,
SNCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PARP
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
B lymphocyte (IgM memory) of spleen
B lymphocyte (naive) of spleen
Plasma cell of spleen
Tonsil
Olfactory bulb
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
PARP1 Promotes Heart Regeneration and Cardiomyocyte Proliferation.
The luciferase-based in vivo protein-protein interaction assay revealed that CHK1 promotes PP2A and …
Respiratory Virus-Induced PARP1 Alters DC Metabolism and Antiviral Immunity Inducing Pulmonary Immun…
The role of PARP1 in neurodegenerative diseases and aging.
The dynamics and regulation of PARP1 and PARP2 in response to DNA damage and during replication.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer
PD1 and PARP for Maintenance Therapy in NSLLC
Effect of PARP Inhibitors on Glomerular Filtration Rate
PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locall…
PET Imaging of PARP Activity in Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ